drugset / Trial / NCT05886998
Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
RandomizedParallel-groupTriple-blindPrevention
Summary
This study aims to examine the effects of nebulized heparin on the clinical outcomes in adult patients suffering smoke inhalation injury. Patients will be randomized to receive nebulized heparin or an equal volume of normal saline for 14 days and the incidence of acute lung injury will be compared in either group.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-06-03
- Completion
- 2024-06-03
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heparin | Other / unclassified | 5000 iu | Other |